Biocon Expects US Success For Biosimilar Trastuzumab Despite Amgen Launch

 
• By Penelope MacRae
  
Doctor with Mammography - Image
Biocon Confident On Breast Cancer Biosimilar Trastuzumab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Focus On Asia